ÉñÂí¸£ÀûӰƬ

Skip to main content Skip to navigation

Press Releases

Select tags to filter on

Homepage Tags

Themes

Faculty of Arts

Faculty of SEM

Faculty of Social Sciences

Cross-Faculty Centres

University News

Events and Campaigns

Community, Campus and Regional

International

Other tags

Big ideas to improve patient flow in hospitals sought from innovators

The ÉñÂí¸£ÀûӰƬ is calling on innovators and businesses to pitch solutions that will improve patient flow through the hospital.

Wed 26 Jan 2022, 13:11 | Tags: 1 - Research

Partnering with Rolls-Royce and Electroflight to create the battery for world’s fastest all-electric aircraft

· The Rolls-Royce ‘Spirit of Innovation’ aircraft is officially the world’s fastest all-electric aircraft, clocking up speeds of 387.4mph. In order to power the aircraft, the most power dense propulsion battery pack ever assembled in aerospace had to be developed directly supported by researchers from WMG, ÉñÂí¸£ÀûӰƬ using their state-of-the-art battery characterisation and testing facilities


Giving a voice to new parents during the pandemic

A new UK-wide study is looking to give a voice to people who became parents for the first time during the pandemic, in order to learn how they can be best supported.

Mon 24 Jan 2022, 11:26 | Tags: Psychology COVID-19 Science and Technology

New Loqski glass fibre ski lock to keep your skis safe this season

Loqski is a pocketable device locking skis and poles together, WMG at the ÉñÂí¸£ÀûӰƬ have helped them manufacture the locks affordably and sustainably


New style of arch bridge architecture shaped by nature

A new style of arch bridges that are more robust than ever and inspired by nature have been found by a researcher from the ÉñÂí¸£ÀûӰƬ.

Tue 18 Jan 2022, 09:55 | Tags: School of Engineering

Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the ÉñÂí¸£ÀûӰƬ

(AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the ÉñÂí¸£ÀûӰƬ.


Latest news Newer news Older news

Let us know you agree to cookies